Medical Communications

Showing 15 posts of 6408 posts found.

leipzig_skyline

FlyPharma Conference Europe: New dates and location announced

April 4, 2022 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

FlyPharma Conferences are pleased to announce that FlyPharma Europe is returning as a live, in-person event in 2022.

FDA places two clinical holds on CytoDyn HIV and COVID-19 programmes

April 1, 2022 Medical Communications

The FDA has placed a partial hold on CytoDyn’s HIV program, and a full clinical hold on its COVID-19 program …

Biomodex launches clear cartridges for neurovascular training

April 1, 2022 Medical Communications

Biomodex has announced the launch of clear cartridges for use with Biomodex’s EVIAS and EVIAS Plus stations.The cartridges are 3D …

Isturisa effective in treating rare Cushing’s disease

April 1, 2022 Medical Communications

Recordati Rare Diseases has announced the publication of positive results from the Phase III LNC 4 study, confirming the efficacy …

UK app launched for people living with glaucoma

April 1, 2022 Medical Communications

Santen UK has launched a new app for people living with glaucoma, in partnership with Glaucoma UK, the leading charity …

After pressure from patients, ALS drug reviewed by FDA

March 25, 2022 Medical Communications

The FDA is meeting next week to review a drug closely watched for ALS, also known as Lou Gehrig’s disease, …

Angle PLC announces identifying therapeutic targets in TNBC patients

March 25, 2022 Medical Communications

A leading cancer research institute in Milan, Italy, Fondazione IRCCS Istituto Nazionale dei Tumori, has published results of a study …

FDA grant Breakthrough Therapy Designation for RSV vaccine candidate in older adults

March 25, 2022 Medical Communications

Pfizer has announced that its respiratory syncytial virus (RSV) vaccine candidate has received Breakthrough Therapy Designation from the FDA, for …

ViiV Healthcare announces label update for long-acting HIV treatment

March 25, 2022 Medical Communications

The FDA has approved a label update for Cabenuva (cabotegravir, rilpivirine), which makes the oral lead-in with cabotegravir and rilpivirine …
guy_photo_2022_002

Ipsen appoints Guy Oliver as General Manager, UK & Ireland

March 21, 2022 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Ipsen have announced the appointment of Guy Oliver as General Manager of its UK and Ireland affiliate. Guy brings a …
moderna_norwood_plant

Moderna seeks FDA authorisation for fourth COVID-19 jab for adults

March 18, 2022 Medical Communications

Moderna has requested an EUA from the FDA for a fourth dose of its COVID-19 vaccine, as a booster for …

NIH fund research for Short Bowel Syndrome

March 18, 2022 Medical Communications

A Saint Louis University School of Medicine physician-scientist has received funding of $428,020, from the National Institutes of Allergy and …

GSK halts new clinical trials in Russia

March 18, 2022 Medical Communications

Britain’s second biggest drugmaker, GlaxoSmithKline (GSK), has joined other pharmaceutical companies including Pfizer, sharing that it will not start clinical …
astrazeneca_sign_sky

AstraZeneca could abandon US regulatory efforts for COVID-19 vaccine

March 18, 2022 Medical Communications

The Oxford/AstraZeneca vaccine has not yet been approved in the US, and has not been submitted for Emergency Use Authorisation …

Valneva provides regulatory update on COVID-19 vaccine candidate

March 11, 2022 Medical Communications

Valneva has announced an update on the regulatory review of its inactivated COVID-19 vaccine candidate VLA2001, by the CHMP.The company …
The Gateway to Local Adoption Series

Latest content